(Q59358991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

A pharmacokinetic and pharmacodynamic study of the new anthracycline pirarubicin in breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

author name string

A Monnier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

N Poutignat

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

P Hérait

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

17 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

75-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00686340

17 September 2019

exact match

0 references

cites work

Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin

1 reference

12 December 2020

Association of bolus tetrahydropyranyl adriamycin and 120 hours continuous 5-fluorouracil infusion in patients with metastatic breast cancer

1 reference

12 December 2020

A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokinetics

1 reference

12 December 2020

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

1 reference

12 December 2020

Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin)

1 reference

12 December 2020

Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

1 reference

12 December 2020

Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.

1 reference

12 December 2020

Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients

1 reference

12 December 2020

Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin

1 reference

12 December 2020

Pharmacodynamics in cancer therapy

1 reference

12 December 2020

Tetrahydropyranyl derivatives of daunomycin and adriamycin

1 reference

12 December 2020

Pirarubicin in advanced breast cancer: a French cooperative phase II study

1 reference

12 December 2020

Phase I clinical trial of a new anthracycline: 4'-o-tetrahydropyranyl adriamycin

1 reference

12 December 2020

Phase I study of pirarubicin

1 reference

12 December 2020

Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy

1 reference

12 December 2020

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol

1 reference

12 December 2020

Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities

1 reference

12 December 2020

Pharmacokinetics of doxorubicin in sarcoma patients

1 reference

12 December 2020

Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.

1 reference

12 December 2020

Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patients

1 reference

12 December 2020

[Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)]

1 reference

12 December 2020

Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1742853%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference